Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Ciba Responds to International Narcotics Control Board Report SUMMIT, N.J., Feb. 28, 1996 -- The International Narcotics Control Board (INCB), an office of the United Nations, today released their 1995 Annual Report, which addresses, among other topics, the increased use of methylphenidate in Attention Deficit Disorder (ADD) in the United States over the last few years. In this report, the INCB expresses their opinion regarding the increased usage and mentions Ritalin(R) (methylphenidate hydrochloride). Over the past several years, increased knowledge and better education about ADD has led to increased, accurate diagnosis of the disorder by physicians. Patient support groups have played a key role in these educational efforts. Ciba, like many pharmaceutical companies, supports the educational needs of many patient groups as such support groups are credible, reliable sources of information to their members. The safety and efficacy of Ritalin have been well documented for over 40 years. Hundreds of clinical studies around the world have demonstrated the positive impact of this important therapeutic drug in the treatment of ADD. Ciba supports only the appropriate use of its medications and is concerned about reports of Ritalin abuse. Ciba monitors the reported abuse of all its medications, and continues to diligently track these events. The Company continues to work with all appropriate regulatory agencies to address these issues. Ciba has also developed a nationwide campaign in the US to inform and educate physicians, pharmacists, parents and patients as to the proper use of Ritalin and its administration in both the home and school environment. To date, Ciba has not been contacted by any representative of the INCB. Ciba is interested in discussing the INCB's report with them directly, and to provide them with the Company's views on some of the issues which in Ciba's opinion may have been misrepresented. CONTACT: Todd Forte of Ciba Pharmaceuticals, 908-277-7588 E-mail this page to a friend or colleague! To print, use this version